| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2008: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Research Abstract |
I examined three issues related to the supply of and demand for generic pharmaceuticals. I find that: 1) financial incentives to dispense generics increase generic adoption, but their impact is limited under the current pricing rule in Japan. 2) As in other markets, brand revenues explain generic entry, but the number of entrants is also sensitive to the prescription pattern driven by the price regulation and healthcare system unique in Japan. 3) Prior to 2010, government policies did not provide proper incentives for pharmacies to boost generic substitution.
|
